Browse Wiki & Semantic Web

Jump to: navigation, search
Http://dbpedia.org/resource/T cell/histiocyte-rich large B-cell lymphoma
  This page has no properties.
hide properties that link here 
  No properties link to this page.
 
http://dbpedia.org/resource/T_cell/histiocyte-rich_large_B-cell_lymphoma
http://dbpedia.org/ontology/abstract T-cell/histiocyte-rich large B-cell lympho … T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a malignancy of B cells. B-cells are lymphocytes that normally function in the humoral immunity component of the adaptive immune system by secreting antibodies that, for example, bind to and neutralize invasive pathogens. Among the various forms of B-cell lymphomas, THRLBCL is a rarely occurring subtype of the diffuse large B-cell lymphomas (DLBCL). DLBCL are a large group of lymphomas that account for ~25% of all non-Hodgkin lymphomas worldwide. THRLBCL is distinguished from the other DLBCL subtypes by the predominance of non-malignant T-cell lymphocytes and histiocytes over malignant B-cells in its tumors and tissue infiltrates. THRLBCL commonly afflicts middle-aged individuals but has been diagnosed in rare pediatric cases. The disease usually presents with lymphadenopathy, i.e. bulky enlargements of lymph nodes in the neck, arm pit, or groin. However, most cases are at an advanced stage at diagnoses: further examinations frequently reveal that the disease has spread to multiple internal organs and tissues. The course of the disease is usually characterized as being poorly responsive to treatment: the disease's survival rates in past studies have been only ~46%. However, recent studies suggest that novel treatments can improve these survival rates. Many studies have found that THRLBCL can overlap with the variant form of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). That is, some cases of variant NLPHL, which is a relatively indolent malignancy, share with THRLBCL similar disease presentations, histologies (i.e. microscopic appearances), genetic abnormalities, and apparent etiologies. Indeed, NLPHL can, in rare cases, progress into THRLBCL. Comapared to THRLBCL, however, these variant NLPHL cases are less aggressive, are more responsive to treatment, and have a better prognosis. Thus, THRLBCL and NLPHL may be biologically related diseases that represent opposite ends of a severity spectrum.sent opposite ends of a severity spectrum.
http://dbpedia.org/ontology/wikiPageID 62948115
http://dbpedia.org/ontology/wikiPageLength 18208
http://dbpedia.org/ontology/wikiPageRevisionID 1084827970
http://dbpedia.org/ontology/wikiPageWikiLink http://dbpedia.org/resource/Hydroxydoxorubicin + , http://dbpedia.org/resource/Cyclophosphamide + , http://dbpedia.org/resource/Nasopharynx + , http://dbpedia.org/resource/CD20 + , http://dbpedia.org/resource/Bone_marrow_examination + , http://dbpedia.org/resource/Protooncogene + , http://dbpedia.org/resource/MYC + , http://dbpedia.org/resource/CREBBP + , http://dbpedia.org/resource/Chemotherapy + , http://dbpedia.org/resource/Oncogene + , http://dbpedia.org/resource/B_cell + , http://dbpedia.org/resource/Vincristine + , http://dbpedia.org/resource/Histiocyte + , http://dbpedia.org/resource/Histology + , http://dbpedia.org/resource/Neoplastic + , http://dbpedia.org/resource/Pathogen + , http://dbpedia.org/resource/Prednisone + , http://dbpedia.org/resource/MUC1 + , http://dbpedia.org/resource/Adaptive_immune_system + , http://dbpedia.org/resource/B-cell_lymphoma + , http://dbpedia.org/resource/Prednisolone + , http://dbpedia.org/resource/CD4 + , http://dbpedia.org/resource/Bcl-2 + , http://dbpedia.org/resource/SOCS1 + , http://dbpedia.org/resource/Reed-Sternberg_cell + , http://dbpedia.org/resource/Non-Hodgkin_lymphoma + , http://dbpedia.org/resource/Lymphadenopathy + , http://dbpedia.org/resource/CD19 + , http://dbpedia.org/resource/Medical_imaging + , http://dbpedia.org/resource/Reactive_lymphocyte + , http://dbpedia.org/resource/Oncology + , http://dbpedia.org/resource/JUNB + , http://dbpedia.org/resource/Category:Lymphoma + , http://dbpedia.org/resource/Reed%E2%80%93Sternberg_cell + , http://dbpedia.org/resource/Regulation_of_transcription_in_cancer + , http://dbpedia.org/resource/Immunodeficiency + , http://dbpedia.org/resource/Malaise + , http://dbpedia.org/resource/Thyroid_gland + , http://dbpedia.org/resource/Transcription_coregulator + , http://dbpedia.org/resource/Gastrointestinal_tract + , http://dbpedia.org/resource/Lymph_nodes + , http://dbpedia.org/resource/CD8 + , http://dbpedia.org/resource/Fever + , http://dbpedia.org/resource/Night_sweats + , http://dbpedia.org/resource/Immunotherapy + , http://dbpedia.org/resource/REL + , http://dbpedia.org/resource/PD-1 + , http://dbpedia.org/resource/Cell_nuclei + , http://dbpedia.org/resource/CD5_%28protein%29 + , http://dbpedia.org/resource/Cytotoxic_T_cell + , http://dbpedia.org/resource/Chromosomal_translocation + , http://dbpedia.org/resource/PAX5 + , http://dbpedia.org/resource/Liver_function_tests + , http://dbpedia.org/resource/B_symptoms + , http://dbpedia.org/resource/Rituximab + , http://dbpedia.org/resource/Diffuse_large_B-cell_lymphoma + , http://dbpedia.org/resource/Response_rate_%28medicine%29 + , http://dbpedia.org/resource/Morphology_%28biology%29 + , http://dbpedia.org/resource/BCL6 + , http://dbpedia.org/resource/CD163 + , http://dbpedia.org/resource/Immunoblast + , http://dbpedia.org/resource/CD10 + , http://dbpedia.org/resource/Dendritic_cell + , http://dbpedia.org/resource/Tumor_suppressor + , http://dbpedia.org/resource/Immunophenotyping + , http://dbpedia.org/resource/Thymus + , http://dbpedia.org/resource/Mutation + , http://dbpedia.org/resource/Gene + , http://dbpedia.org/resource/Humoral_immunity + , http://dbpedia.org/resource/Gene_amplification + , http://dbpedia.org/resource/T-cell + , http://dbpedia.org/resource/Category:Non-Hodgkin_lymphoma + , http://dbpedia.org/resource/Ubiquitin + , http://dbpedia.org/resource/SGK1 + , http://dbpedia.org/resource/Lymphocytes + , http://dbpedia.org/resource/CD79a + , http://dbpedia.org/resource/CD22 + , http://dbpedia.org/resource/Antibodies + , http://dbpedia.org/resource/CD3_%28immunology%29 + , http://dbpedia.org/resource/Follicular_dendritic_cells + , http://dbpedia.org/resource/Nodular_lymphocyte_predominant_Hodgkin_lymphoma + , http://dbpedia.org/resource/Hematology + , http://dbpedia.org/resource/Pancreas + , http://dbpedia.org/resource/Hodgkin_disease + , http://dbpedia.org/resource/Survival_rate + , http://dbpedia.org/resource/CD57 + , http://dbpedia.org/resource/Mutations + , http://dbpedia.org/resource/CD68 + , http://dbpedia.org/resource/DUSP2 + , http://dbpedia.org/resource/MAPK/ERK_pathway + , http://dbpedia.org/resource/CHOP_%28chemotherapy%29 + , http://dbpedia.org/resource/Centroblast + , http://dbpedia.org/resource/Histiocytes + , http://dbpedia.org/resource/Soft_tissue +
http://dbpedia.org/property/differential Variant form of nodular lymphocyte predominant Hodgkin lymphoma
http://dbpedia.org/property/field http://dbpedia.org/resource/Hematology + , http://dbpedia.org/resource/Oncology +
http://dbpedia.org/property/name T-cell/histiocyte-rich large B-cell lymphoma
http://dbpedia.org/property/synonyms THRLBCL
http://dbpedia.org/property/wikiPageUsesTemplate http://dbpedia.org/resource/Template:Reflist + , http://dbpedia.org/resource/Template:Infobox_medical_condition_%28new%29 +
http://purl.org/dc/terms/subject http://dbpedia.org/resource/Category:Lymphoma + , http://dbpedia.org/resource/Category:Non-Hodgkin_lymphoma +
http://www.w3.org/ns/prov#wasDerivedFrom http://en.wikipedia.org/wiki/T_cell/histiocyte-rich_large_B-cell_lymphoma?oldid=1084827970&ns=0 +
http://xmlns.com/foaf/0.1/isPrimaryTopicOf http://en.wikipedia.org/wiki/T_cell/histiocyte-rich_large_B-cell_lymphoma +
http://xmlns.com/foaf/0.1/name T-cell/histiocyte-rich large B-cell lymphoma
owl:sameAs https://global.dbpedia.org/id/C8uhF + , http://dbpedia.org/resource/T_cell/histiocyte-rich_large_B-cell_lymphoma + , http://www.wikidata.org/entity/Q55787214 +
rdf:type http://dbpedia.org/ontology/Disease + , http://www.wikidata.org/entity/Q12136 +
rdfs:comment T-cell/histiocyte-rich large B-cell lympho … T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a malignancy of B cells. B-cells are lymphocytes that normally function in the humoral immunity component of the adaptive immune system by secreting antibodies that, for example, bind to and neutralize invasive pathogens. Among the various forms of B-cell lymphomas, THRLBCL is a rarely occurring subtype of the diffuse large B-cell lymphomas (DLBCL). DLBCL are a large group of lymphomas that account for ~25% of all non-Hodgkin lymphomas worldwide. THRLBCL is distinguished from the other DLBCL subtypes by the predominance of non-malignant T-cell lymphocytes and histiocytes over malignant B-cells in its tumors and tissue infiltrates.ells in its tumors and tissue infiltrates.
rdfs:label T cell/histiocyte-rich large B-cell lymphoma
hide properties that link here 
http://en.wikipedia.org/wiki/T_cell/histiocyte-rich_large_B-cell_lymphoma + http://xmlns.com/foaf/0.1/primaryTopic
http://dbpedia.org/resource/T_cell/histiocyte-rich_large_B-cell_lymphoma + owl:sameAs
 

 

Enter the name of the page to start semantic browsing from.
Retrieved from "http://b-kaempgen.de/index.php/Special:BrowseSW/http:-2F-2Fdbpedia.org-2Fresource-2FT_cell-2Fhistiocyte-2Drich_large_B-2Dcell_lymphoma"